Foot and ankle disease, especially hallux valgus
Conditions
Interventions
A:flurbiprofen axetil intravenous injection
B: oral celecoxib
C:BTDS
Sponsors
Xiangya Hospital, Central South University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) patients between the ages of 18 years and 75 years; (2) patients who are to undergo surgery for mild and low-moderate hallux valgus deformities; (3) patients who could understand the study procedures and assessment and agreed to participate in the study by giving written informed consent.
Exclusion criteria
Exclusion criteria: patients who had angina pectoris within the previous 6 months; patients who had congestive heart failure and arrhythmia; patients who had adverse cardiovascular and cerebrovascular events and coronary artery bypass grafting or an interventional operation within the previous 3 months; patients who had taken opioids preoperatively; patients who had a joint infection or systemic infection; patients who had chronic pain caused by osteoarthritis or bone tumors; and patients who had other diseases or conditions that did not fit into the study after being assessed by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VAS score of perioperative period; | — |
Countries
China
Contacts
Public ContactLiu Hua
Xiangya Hospital, Central South University?
Outcome results
None listed